EpiCypher
A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a biotechnology company developing transformative technologies and delivering superior products to researchers worldwide. EpiCypher manufactures and sells recombinant "designer" modified nucleosomes (dNucs), including the SNAP-ChIP® product family for quantitative ChIP applications, as well as recombinant histone binding proteins, peptides and antibodies, and offers a broad range of custom substrate manufacturing and assay development services.
Last updated on
About EpiCypher
Founded
2012Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$3MCategory
Sector
Commercial Physical and Biological ResearchIndustry Group
Research, Development, and Testing ServicesIndustry
BiotechnologyLocation
City
DurhamState
North CarolinaCountry
United StatesEpiCypher
Find your buyer within EpiCypher